mHealth program reduces caregiver burden for dementia-diabetes caregivers in RCT
This pilot randomized controlled trial evaluated the effectiveness of a 12-week mHealth supportive care program for family caregivers of individuals with both dementia and type 2 diabetes mellitus. The study recruited 60 eligible caregivers from urban and rural communities in Xiamen, China, between September 2022 and January 2023. Caregivers were required to be legally related to the patient, provide care for more than 8 hours per day for at least one month, be conscious adults with basic literacy, own and be able to use a smartphone, and provide informed consent. Their care recipients were aged over 60 years and met diagnostic criteria for both dementia and type 2 diabetes. Participants were randomly allocated 1:1 to either the intervention group (n=30) or a wait-list control group (n=30). The intervention group received the mHealth program via the 'Xiamen i-Health' platform, which included six core modules updated biweekly and on-demand teleconsultation, in addition to conventional offline health education. The control group received only conventional monthly 1-hour home-visit health education. The primary outcome was caregiver burden measured by the Caregiver Burden Inventory (CBI). Secondary outcomes were social support (Social Support Rating Scale; SSRS) and dementia care knowledge (Dementia Care Knowledge Scale; DCKS). Assessments were performed at baseline and 3 months post-intervention. Per-protocol analysis included 55 participants (intervention n=28, control n=27). Post-intervention, the intervention group showed a significantly greater reduction in CBI scores compared to the control group (between-group difference, Z=-3.534, P<.001, r=0.477). The intervention group also demonstrated significantly greater improvements in SSRS scores (Z=2.494, P=.01) and DCKS scores (Z=-4.233, P<.001, r=0.570). Subgroup analyses indicated the reduction in caregiver burden was more pronounced among male, younger (60 years), physical labor, and lower-income caregivers. No intervention-related adverse events were reported. The study concludes the mHealth program effectively reduced burden and improved outcomes for these caregivers.